EP0221116A1 - Determination du poids moleculaire de proteines - Google Patents

Determination du poids moleculaire de proteines

Info

Publication number
EP0221116A1
EP0221116A1 EP86902779A EP86902779A EP0221116A1 EP 0221116 A1 EP0221116 A1 EP 0221116A1 EP 86902779 A EP86902779 A EP 86902779A EP 86902779 A EP86902779 A EP 86902779A EP 0221116 A1 EP0221116 A1 EP 0221116A1
Authority
EP
European Patent Office
Prior art keywords
molecular weight
protein
proteins
components
igg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP86902779A
Other languages
German (de)
English (en)
Other versions
EP0221116A4 (fr
Inventor
Jeffrey R. Davies
Milton T. W. Hearn
Patrick B. Marley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
Commonwealth Serum Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Serum Laboratories filed Critical Commonwealth Serum Laboratories
Publication of EP0221116A1 publication Critical patent/EP0221116A1/fr
Publication of EP0221116A4 publication Critical patent/EP0221116A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • G01N27/44704—Details; Accessories
    • G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
    • G01N27/44721—Arrangements for investigating the separated zones, e.g. localising zones by optical means
    • G01N27/44726—Arrangements for investigating the separated zones, e.g. localising zones by optical means using specific dyes, markers or binding molecules

Definitions

  • This invention relates to compositions for use in the determination of molecular weights of proteins, and to methods utilising such compositions.
  • the technique of Western transfer and protein blotting of electrophoretically separated protein mixtures is now widely applied in biological sciences.
  • the technique employs electrical current to effect the transfer of proteins resolved on polyacrylamide (or other polymeric) gels onto the surface of treated semi-rigid or rigid membrane or paper support which strongly bind the proteins.
  • the technique was discussed by S.Gershoni and G.Paladie (Anal.Bioch. (1983) 131, 1-15) .
  • Methods to classify the transferred proteins according to their molecular weight require that suitable protein standards of known molecular weight are also simultaneously transferred from the same, adjacent or non-contiguous regions of the separation gel onto the same, adjacent or non-contiguous regions of the treated semi-rigid or rigid paper or membrane support.
  • the region of paper or membrane support containing electrophoretically transferred molecular weight markers is removed and stained for protein.
  • Molecular weight markers suitable for the above methods are commercially available from several companies.
  • radioactive labels e.g. radiolabelled antibodies, or Protein A
  • compositions for use in the determination of the molecular weight(s) of protein(s), which comprises at least one protein or polypeptide of known molecular weight selected from the group consisting of the immunoglobulins and fragments and polymers thereof (hereinafter referred to as Ig Components) .
  • compositions comprising at least one protein or polypeptide of known molecular weigh (s) selected from the group consisting of immunoglobulin G and fragments and polymers thereof (hereinafter referred to as IgG Components) .
  • the composition of this aspect of the invention will comprise two or more Ig Components, preferably in equal amounts, and typically at least four or five such components.
  • the Ig Components are selected so as to have calibrated molecular weights falling at intervals, preferably at approximately regular intervals, over a range of molecular weights.
  • IgG Components may be selected to cover the range of approximately 200 - 25 KDa, preferably with regular molecular weight intervals between the components.
  • the Ig Components may be derived from different animal species as described in greater detail below.
  • the invention thus provides a composition comprising proteins of defined molecular weight derived, from different Ig classes, preferably from immunoglobulin G (gammaglobulin) , which can be used to provide molecular weight markers on
  • composition of the invention allows simultaneous detection of antigen(s) and molecular weight standards thus providing a measure of the efficiency of the transfer and detection procedure when markers of the same or cross-reacting species to the antigen(s) species are used.
  • the range of molecular weight components in the compositions of this invention may be obtained by fragmentation of an immunoglobulin molecule such as the IgG molecule by known methods into the various combinations of heavy and light chain components and other components by partial or full reductive alkylation, enzymatic digestion, chemical cleavage with polymerisation of the various fragments where necessary.
  • this invention provides a method for the detection and/or determination of the molecular weight(s) of one or more sample proteins, which method comprises the steps of:
  • the step of electrophoretic resolution may be conducted under one- or two-dimensional conditions.
  • a sodium dodecyl sulphate-polyacrylamide gel is used for this resolution.
  • Detection of the resolved sample protein(s) and Ig Components may be performed directly in the polymeric gel.
  • an intermediate transfer step may be performed whereby the resolved materials are transferred onto a separate support, with the step of detection and comparison being performed on the transferred materials, for example by electrophoretic transfer onto a semi-rigid or rigid support following the technique of Western transfer and protein blotting described above.
  • the immunoglobulin fragments and particularly IgG fragments, they can be electrophoretically transferred onto semi-rigid or rigid polymeric films where they can be detected using a variety of reagents including protein A, enzyme-linked anti-immunoglobulins (intact, H- or L- chain) , and radio-labelled analogues.
  • immunoglobulins and fragments thereof from various and appropriate species, including human, mouse, goat, bovine, rabbit etc., this method thus allows reliable molecular weight determinations and also quantification of transfer and immunodetection efficiency.
  • human immunoglobulin fragments can be used in detection systems where anti-human immunoglobulins are employed as.second antibodies.
  • Starting materials for the preparation of the preferred IgG include purified gammaglobulin from a variety of animal species (e.g. human, rabbit, rat, mouse, goat” etc.) derived directly from blood or monoclonal sources.
  • the starting material consists only of the major subtype of IgG where applicable.
  • Dissociation of gammaglobulin chains into combinations of heavy (H) and light (L) polypeptides can be achieved by incubating the gammaglobulin with a reducing agent (e.g. dithiothreitol, mercaptoethanol) over a range of concentrations and subsequently alkylating the reduced proteins with a suitable alkylating reagent such as iodoacetamide or iodoacetic acid.
  • a reducing agent e.g. dithiothreitol, mercaptoethanol
  • a suitable alkylating reagent such as iodoacetamide or iodoacetic acid.
  • the components in these mixtures can be isolated by a variety of chromatographic methods including gel filtration (size exclusion) ion exchange chromatography and affinity chromatography such as with Protein A as the ligand.
  • the preferred reagent is obtained by appropriate reconstitution of these combinations to form a product with equal amounts of these components.
  • these components may be treated with various cross-linking reagents, for example with formaldehyde or glutaraldehyde, the bisoxirans, or with bifunctional reagents including para-azidophenacyl bromide, the N-succinimidyl esters (e.g.
  • N-succinimidyl (4-iodoacetyl) aminobenzoate succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate) and the C6-8 alkandiimidates (e.g. dimethyladipimidate; dimethyl pimelimidate, etc.), over a range of concentrations to produce oligomeric IgG fragments.
  • C6-8 alkandiimidates e.g. dimethyladipimidate; dimethyl pimelimidate, etc.
  • Molecular weight markers can also be generated from this immunoglobulin G starting material by enzymatic digestion.
  • IgG is digested with various proteolytic enzymes (e.g. papain, pepsin, plasmin) to yield the desired fragments.
  • IgG fragments of different molecular weight are then isolated. The isolation can be achieved by a variety of methods including gel filtration, ion exchange chromatrography and affinity chromatography such as Protein A affinity chromatography.
  • the fragments may be treated with a crosslinking reagent (e.g. glutaraldehyde, para-azidophenacyl bromide, etc.) over a range of concentrations to produce mixtures of IgG fragments with varying degrees of polymerization.
  • a crosslinking reagent e.g. glutaraldehyde, para-azidophenacyl bromide, etc.
  • IgG fragments may be generated by other methods of chemical fragmentation (e.g. using cyanogen bromide) , then processed and crosslinked as described for the alkylated and enzymatically derived fragments.
  • IgG -fragments obtained by one or any of the above methods may be mixed to obtain a product with the desired--mixture of fragments.
  • the preferred gammaglobulin derived molecular weight markers of this invention can be used on SDS-polyacrylamide gels as standards. Similarly, following transfer, they function as standards on "Western Blots".
  • the products can be used on all SDS-PAGE systems (e.g. Reisfeld, R.A. , Lewis, ⁇ _J. and Williams, D_E. Nature (1962) 195 281-283; Laemmeli, U.K., Nature (1970) 227 680-685; Weber, K, and Osborne, M-, J.Biol.Che . (1969) 244 4406-4412) which require molecular weight markers.
  • the immunoglobulin derived molecular weight markers in accordance with this invention can be chosen from any species of Ig when used as molecular weight standards on SDS-PAGE gels.
  • the species of Ig used is important.
  • sample protein(s) and Ig Components as molecular weight standards are electrophoresed on an SDS polyacrylamide gel and electrotransferred to a charged or reactive support (e.g. nitrocellulose or nylon membranes or diazophenylthio paper) to produce a "Western Blot". Reactive or charged sites on the support that are not occupied are blocked with a blocking buffer usually containing a detergent (e.g.
  • Triton X-100, Tween 20) and/or protein e.g. gelatin, albumin
  • the support is incubated with buffer containing antibody (the primary antibody) directed against the required antigen.
  • the Ig Components used as molecular weight standards should be of the same species as the primary antibody. Bound primary antibody and the Ig Components can be detected by incubating the blot with a variety of reagents including labelled or enzyme conjugated Protein A, or a labelled or enzyme conjugated secondary antibody directed against the species Ig of the primary antibody. Thus simultaneous detection of antigen and molecular weight markers is achieved. Such use of immunoglobulin " derived molecular weight markers also provides a measurement of the sensitivity of the immunodetection and transfer procedures.
  • Figure 1 is a calibration curve for IgG Molecular Weight Standards against conventional molecular weight standards (M, H and R refer to approx. 5 ⁇ g loads of immuno standard from mouse, human and rabbit IgG respectively, and these are bordered by 5 ⁇ g loads of low and high molecular weight standards respectively of a commercial reagent (Pharmacia) ; and
  • Figure 2 illustrates the use of the IgG molecular weight standards in a Western blotting procedure. A description of the protocols of the various tracts is to be found in Example 4.
  • Untreated gammaglobulin and reduced and alkylated gammaglobulin were then subjected to SDS-PAGE according to the method of Laemmeli on a 10% gel. 2 ⁇ g of protein was loaded per sample. The gel was then stained for protein by the silver staining method of Wray. (Wray W., Boulikas, T., Wray, V.P. & Hancock, R. Analytical Biochem. (1981) 118 197-203).
  • the silver stain revealed that all possible breakdown products from the reduction and alkylation of gammaglobulin were generated using both concentrations of dithiothreitol, and corresponded to H_L 2 , H-L, H Fundamental, HL, H and L chains.
  • Plots of the logarithm of molecular weight versus relative mobility demonstrated linear dependencies for the various IgG Components, which included components of molecular weight of 150, 125, 100, 75, 50 and 25 KDa respectively.
  • Gammaglobulin fragments were prepared and electrophoresed as described in Example 1 and electrotransferred to nitrocellulose according to the method of Towbin (Towbin, H. , Staehelin,, T. , Gordon, J. Proc.Natl.Acad.Sci.USA (1979) 76 4350-4354) . Electrotransfer was carried out for 3 hours at 70 volts at 2°C. Following transfer the nitrocellulose membrane (NCM) was incubated at 20mM Tris/Cl pH 7.5, 0.05% Triton X-100, 5% gelatin, 150mM NaCl buffer (Buffer A) for 60 minutes at room temperature then incubated in 5ml of
  • the gamma globulin fragments were obtained from IgG from three species (human, mouse and rabbit) as follows:-
  • Hu an IgG was isolated from myeloma serum by Protein A Sepharose and consisted mainly of IgG, . Aliquots of protein concentration 3.75 mg/mL were made ImM and 4mM " with respect to dithiothreitol and incubated at room temperature for 30 minutes. The reduction reaction was stopped by the addition of iodoacetamide (final concentration 8mM) and after ten minutes at room temperature, the solutions were dialysed against 50mM Tris/HCl, 50mM NaCl pH 8.0. Following preliminary analysis on 5-16% polyacrylamide gels in the presence of SDS and visualization of the proteins by the silver staining method of Wray (Wray, S., Boulikas, T., Wray, V.P.
  • Mouse monoclonal IgG was isolated from ascites fluid by Protein A Sepharose. Aliquots of protein concentration 0.2 mg/mL were made 0.25, 1 and 4mM with respect to dithiothreitol and incubated at room temperature for 30 minutes. The reduction reaction was stopped by the addition of iodoacetamide (final concentration 8mM) and after ten minutes at room temperature, the solutions were dialysed against 50mM Tris/HCl, 50mM NaCl pH 8.0. Following preliminary analysis on 5-16% polyacrylamide gels in the presence ⁇ f SDS and visualization of the proteins by the silver staining method of Wray, the three solutions were blended to produce a reagent with approximately equal quantities of all possible combinations of light and heavy chains.
  • Rabbit IgG was isolated from serum by Protein A Sepharose and divided into three aliquots. One aliquot was made 16mM with respect to dithiothreitol and incubated at room temperature for 30 minutes. Alkylation was effected by making the solution 32mM with respect to iodoacetamide and leaving at room temperature for ten minutes. The solution was then dialysed against 50mM Tris/HCl, 50mM NaCl pH 8.0. The second aliquot was incubated with papain (Worthington 28 /mg) in the presence of lOmM cysteine at 37° for 1 1/2 hours.
  • the reaction was stopped by the addition of iodoacetamide and the solution dialysed against 50mM Tris/HCl, 50mM NaCl pH 8.0.
  • the Fc fragments of the digested IgG were isolated on Protein A Sepharose and the product dialysed against 50mM phosphate 145mM NaCl pH 7.0. This material was reduced by making the solution 14mM with respect to dithiothreitol and incubating at room temperature for 30 minutes. Alkylation was effected by making the solution 30mM with respect to iodoacetamide followed by dialysis against the pH 8.0 tris buffer. The third aliquot was not treated further. All three aliquots were examined by SDS-PAGE and silver stained as for the human and mouse IgG. From this data, a blend was made to produce a mixture containing native and fragmented IgG.
  • Two 5-16% polyacrylamide gels were prepared with slots to accommodate single samples at each side and with the rest of the gel dedicated to a single sample.
  • 5 ⁇ g of the mouse immuno standard (described in Example 3) in SDS buffer was added to the two single side tracks on one gel and 5 ⁇ g of the human immuno standard was added to these tracts on the other gel.
  • 80 ⁇ g (in 200 ⁇ l) of an extract of B.Pertussis (Whooping Cough) bacteria was loaded on to the middle, wide track of each gel. The gels were run at 36m.amp constant current for approximately 2 1/2 hours.
  • the separated proteins were then transferred to nitrocellulose membranes by a constant voltage of 70 volts for 16 hours.
  • the nitrocellulose membranes were cut into strips and transferred to BioRad incubation trays.
  • the strips containing B.Pertussis antigens were probed with various mouse and human antibodies. All strips (including immuno standards) were finally probed with either Horse Radish Peroxidase (HRP)-conjugated goat anti-mouse IgG or with HRP-conjugated goat anti-human IgG, depending on the species from which the primary antibody and the immuno standards had been derived.
  • HRP Horse Radish Peroxidase
  • Tracks 1-4 correspond to B.Pertussis extract probed with (1) mouse hyperimmune (vaccine) serum, (2) mouse polyclonal serum raised against a preparation of filamentous haemagglutin (FHA) purified from B.Pertussis extract, (3) mouse monoclonal anti-FHA and (4) mouse polyclonal anti-pertussigen (major B.Pertussis toxin).
  • the two bridging tracks correspond to the mouse immuno standard.
  • Tracks 5-7 correspond to B.Pertussis extract probed with three different human sera at " 1/100 dilution; from (5) , a patient suspected of having Whooping Cough, (6) a healthy vaccinated individual and (7) a pool of sera from patients known to have low anti-FHA and anti-pertussigen titres by ELISA tests. These are bridged by the human immuno standard.
  • the IgG molecular weight (immuno) standards provide a useful range of molecular weight species to determine the molecular weights of the antigen recognised by the various sera. From the human panel, it is obvious that the overall immunodetection is rather weak, illustrating the usefulness of the standards in checking the effectiveness of the electrophoresis, transfer and immunodetection stages.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Electrochemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Compositions destinées à être utilisées dans la détermination du/des poids moléculaire(s) d'une/de protéine(s) et comprenant au moins une protéine ou un polypeptide d'un poids moléculaire connu sélectionné dans le groupe des composants Ig représentés par les immunoglobulines, en particulier l'immunoglobuline G, ainsi que par des fragments et des polymères dudit groupe. Les méthodes pour la détection et/ou la détermination du/des poids moléculaire(s) d'une ou de plusieurs protéines échantillon utilisant de telles compositions sont également décrites.
EP19860902779 1985-05-01 1986-04-30 Determination du poids moleculaire de proteines. Ceased EP0221116A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU381/85 1985-05-01
AUPH038185 1985-05-01

Publications (2)

Publication Number Publication Date
EP0221116A1 true EP0221116A1 (fr) 1987-05-13
EP0221116A4 EP0221116A4 (fr) 1987-09-15

Family

ID=3771078

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19860902779 Ceased EP0221116A4 (fr) 1985-05-01 1986-04-30 Determination du poids moleculaire de proteines.

Country Status (7)

Country Link
EP (1) EP0221116A4 (fr)
JP (1) JPS63500207A (fr)
CA (1) CA1272938A (fr)
DK (1) DK634486A (fr)
NO (1) NO865333L (fr)
NZ (1) NZ215967A (fr)
WO (1) WO1986006383A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19729248C1 (de) * 1997-07-09 1998-07-09 Jochen Uhlenkueken Standardprotein
JP3432158B2 (ja) * 1998-12-04 2003-08-04 日立ソフトウエアエンジニアリング株式会社 電気泳動方法、電気泳動装置及びそれに用いるマーカー試料
WO2001007920A2 (fr) * 1999-07-27 2001-02-01 Bio-Rad Laboratories, Inc. Reperage automatique pour electrophorese bidimensionnelle
DE10244502B4 (de) * 2002-09-25 2006-06-01 Universität Gesamthochschule Kassel Molekulargewichtsmarker für Proteine und Verfahren zu dessen Herstellung
EP3892989A1 (fr) * 2020-04-07 2021-10-13 Ares Trading S.A. Électrophorèse capillaire sur gel et son utilisation avec des molécules biologiques complexes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107014A (en) * 1976-01-30 1978-08-15 Oriental Yeast Co. Ltd. Isoelectric point markers for gel isoelectric separation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55153724A (en) * 1979-05-17 1980-11-29 Teijin Ltd Preparation of immunoglobulin derivative
CH644131A5 (en) * 1979-05-23 1984-07-13 Teijin Ltd Process for the preparation of immunogammaglobulin
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
CA1260828A (fr) * 1983-07-04 1989-09-26 Masakazu Iwai Agent prophylactique et therapeutique contre les ulceres gastrointestinaux

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107014A (en) * 1976-01-30 1978-08-15 Oriental Yeast Co. Ltd. Isoelectric point markers for gel isoelectric separation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8606383A1 *

Also Published As

Publication number Publication date
EP0221116A4 (fr) 1987-09-15
CA1272938A (fr) 1990-08-21
NZ215967A (en) 1988-05-30
WO1986006383A1 (fr) 1986-11-06
JPS63500207A (ja) 1988-01-21
DK634486D0 (da) 1986-12-30
DK634486A (da) 1987-03-02
NO865333L (no) 1986-12-30

Similar Documents

Publication Publication Date Title
Eng et al. Antibody to bovine choline acetyltransferase and immunofluorescent localisation of the enzyme in neurones
Gadasi et al. Evidence for differential intracellular localization of the Acanthamoeba myosin isoenzymes
White et al. Definition of the antigenic polypeptides in the Sm and RNP ribonucleoprotein complexes
Langeland A Clinical and Immunological Study of Allergy to Hen's Egg White: II, Antigens in Hen's Egg White Studied by Crossed Immunoelectrophoresis (CIE)
Baldwin et al. Immunological identification of the human erythrocyte monosaccharide transporter
Esteves et al. Antigenic similarities among mammalian immunoglobulins
Gilden et al. Immunochemical studies of the major internal polypeptide of woolly monkey and gibbon ape type C viruses
CA1272938A (fr) Standards de masse moleculaire, et leur emploi
Norton et al. Immune labeling of the D and E regions of human fibrinogen by electron microscopy.
Bjerrum et al. Some recent developments of the electroimmunochemical analysis of menbrane proteins. Application of Zwittergent, Triton X-114 and Western blotting technique
ORINO et al. Inhibitory effects of horse serum on immunoassay of horse ferritin
Wilson Studies on the products of peptic digestion of IgA
Bassett et al. STUDIES ON HUMAN ANTIBODIES: III. Amino Acid Composition of Four Antibodies from One Individual
Kosaka et al. Hyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factor
Faulk et al. Characterization of rabbit fast and slow 6· 6S IgG
Gordon Ribonucleases of the rat: II. Immunochemical properties
Fuller et al. Isolation from nurse shark serum of immune 7S antibodies with two different molecular weight H-chains
Tischendorf et al. Immunochemical analyses of human lysozyme in monocytic dyscrasias
Moore et al. Purification and use of the C3d subunit of C3
Kamiyama Immunological cross-reactions and species-specificities of cyanogen bromide cleaved fragments of bovine, goat and sheep serum albumins
Whitaker Immunochemical characterization of bovine brain cathepsin D
Tseng et al. Differential susceptibility of rabbit sIgA subclasses to trypsin cleavage: characterization of the fragments obtained from the g subclass
Mehta et al. Splitting of human thyroglobulin. III. Comparison of fragments obtained during enzymatic digestion and by reduction and alkylation
Kohn et al. The use of alkaline-phosphatase conjugated second antibody for the enhancement of immunoprecipitation techniques on cellulose acetate membranes
Sprouse Determination of molecular weight, isoelectric point, and glycoprotein moiety for the principal skin test-reactive component of histoplasmin

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19861224

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19870915

17Q First examination report despatched

Effective date: 19890523

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19910526

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MARLEY, PATRICK, B.

Inventor name: HEARN, MILTON, T., W.

Inventor name: DAVIES, JEFFREY, R.